Further investigations have leaded to considers PGC-1α as a critical transcriptional co-activator linked to cellular metabolism and mitochondrial biogenesis, and which abnormal expression could further account for the altered neuronal metabolism and diminished mitochondrial density often reported in several AD models [27], [28]. The gene discussed is PPARGC1A; the disease is Alzheimer disease.